Delivery Order 36C26226D0065-36C26226N0409
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 17 awarded a $990,211 delivery order for radiopharmaceuticals to RLS (USA) Inc., a foreign-owned radiopharmacy company specializing in nuclear medicine products for federal healthcare agencies. The contract employs firm fixed pricing and is not designated as a set-aside. RLS (USA) Inc. will perform work at its facility in Lake Mary, Florida, with an ultimate completion date of September 17, 2026. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a firm fixed-price delivery order valued at $432,681.74 by Veterans Integrated Service Network 5 (VISN 5) for the supply of radiopharmaceutical products. The award, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, carries no set-aside designation and represents performance at the contractor's Lake Mary, Florida facility. This delivery order is issued under an...
- RLS (USA) Inc., a radiopharmacy company specializing in nuclear medicine products, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) on January 1, 2026, for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in diagnostic imaging. This firm fixed-price delivery order carries a ceiling value of $91,658.40 and is scheduled for completion by December 31, 2026. The contract will be performed in...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $91,658.40 by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in nuclear medicine diagnostic imaging. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, and will be performed at the contractor's facility in...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $356,461.75 by the Department of Veterans Affairs Veterans Integrated Service Network 5 for the supply of radiopharmaceuticals. The contract, awarded on April 1, 2025, carries a firm fixed price structure and an ultimate completion date of March 31, 2026. Performance will be executed from the contractor's facility in Lake Mary, Florida. This delivery order does not carry a set-aside designation and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a $322,968.95 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 for the supply of radiopharmaceutical products. The award, issued on December 12, 2025, with a completion date of December 11, 2026, does not include a set-aside designation and represents a call against an existing Indefinite Delivery Vehicle. Performance will take...
- RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a delivery order valued at $250,075.29 by the Department of Veterans Affairs' Northern California Health Care System (Veterans Integrated Service Network 21) for radiopharmaceuticals and radiopharmaceutical supplies. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, utilizes firm fixed-price pricing and is not designated as a set-aside contract. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 on January 1, 2026, for the supply of radiopharmaceuticals for nuclear medicine patients. The contract carries a firm fixed-price ceiling value of $493,958.37 with an ultimate completion date of December 31, 2026, and will be performed in Lake Mary, Florida. This delivery order is not designated as a set-aside contract and...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a $18,331.68 firm fixed-price delivery order to RLS (USA) Inc. for NETSPOT GA-68 radiopharmaceutical products under Ordering Period 2 of contract BRX 526C50247. This delivery order, effective September 1, 2025, with an ultimate completion date of December 31, 2025, represents a decrease in unused FY25 funds and does not utilize a set-aside designation. The work will be performed in Lake Mary, Florida, where RLS...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 22, awarded a $752,000 delivery order to RLS (USA) Inc. for radiopharmaceutical supply to VA medical facilities serving the Phoenix and Tucson regions. The contract employs a firm fixed-price delivery order structure under an indefinite delivery indefinite quantity (IDIQ) vehicle, with performance extending through March 31, 2027. No small business set-aside was utilized for this procurement. RLS (USA) Inc.,...
- 36C26226D0065Indefinite Delivery Contract
- 36C26226D0065-36C26226N0409Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a delivery order to RLS (USA) Inc. for radiopharmaceutical base supply services with a ceiling value of $1.56 million, effective April 1, 2026 through March 31, 2027. This firm fixed-price delivery order was issued without set-aside designation and calls for performance at RLS's facility in Lake Mary, Florida. RLS (USA) Inc. is a foreign-owned radiopharmacy company specializing in the supply of nuclear medicine diagnostic and therapeutic imaging agents essential to VA medical centers nationwide, with the capability to distribute time-sensitive radiopharmaceutical products through 31 facilities across 18 states. This delivery order is issued under RLS's existing indefinite delivery vehicle portfolio with the VA, through which the company supplies a comprehensive range of radiopharmaceutical products including fluorodeoxyglucose F-18, technetium-99m derivatives, gallium-67, iodine isotopes, and specialty agents such as Gallium-68 Dotatate (NETSPOT) for nuclear medicine diagnostic procedures. RLS maintains multiple large IDV contracts with various VISN networks, including a $5.0 million contract with VISN 17 extending through 2029 and several million-dollar vehicles with other networks through 2030, establishing the company as a preferred supplier within the VA's radiopharmaceutical procurement enterprise. The delivery order structure enables VISN 22 to procure radiopharmaceuticals on an as-needed basis without requiring separate competitive procurements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6m | 3/4/26 |